A 62-year-old Indian man with HBsAg-positive cirrhosis presents with a 3 cm liver nodule. Biopsy shows well-differentiated HCC. Which histological feature best distinguishes well-differentiated HCC from benign cirrhotic nodules (adenomatous hyperplasia)?

## Histopathology: HCC vs. Benign Cirrhotic Nodules ### The Diagnostic Dilemma: Well-Differentiated HCC **Key Point:** Well-differentiated HCC is histologically challenging to distinguish from adenomatous hyperplasia (benign). The **single most reliable discriminator is the absence of portal tracts and central veins within the nodule** — a feature that reflects loss of the normal acinar architecture. ### Architectural Features | Feature | Well-Differentiated HCC | Adenomatous Hyperplasia | Regenerative Nodule | |---|---|---|---| | **Portal tracts** | Absent or markedly reduced | Present (though may be compressed) | Present | | **Central veins** | Absent or displaced | Present | Present | | **Fibrous capsule** | May be present (not diagnostic) | Absent | Absent | | **Trabecular pattern** | Thickened (>1 cell thick) | Normal (1 cell thick) | Normal | | **Nuclear atypia** | Mild to moderate | Minimal | Minimal | | **Mitotic rate** | Increased | Normal | Normal | **High-Yield:** The **absence of portal tracts and central veins** is the most specific architectural feature because it indicates loss of the normal lobular framework — a hallmark of HCC even when cytological atypia is subtle. ### Why Cytological Features Are Unreliable in Well-Differentiated HCC 1. **Increased mitotic activity** — can be seen in regenerating cirrhotic nodules, especially in active hepatitis 2. **Nuclear pleomorphism** — may be absent in well-differentiated HCC and present in benign nodules with inflammation 3. **These features overlap** between HCC and reactive/regenerative changes **Clinical Pearl:** When a small HCC is well-differentiated and cytologically subtle, immunohistochemistry (GPC3, HSP70, glutamine synthetase) can support the diagnosis, but architectural loss (absent portal tracts) remains the gold standard. ### Fibrous Capsule: A Trap **Warning:** A fibrous capsule is present in ~30% of HCCs and is a sign of **compression** by the tumor, not a feature that distinguishes HCC from benign nodules. Benign nodules do NOT have capsules, but the presence of a capsule in HCC does not help differentiate it from adenomatous hyperplasia. ### Fatty Change: Non-Specific Fatty change (steatosis) can occur in both HCC and benign nodules, especially in metabolic syndrome or NAFLD-related cirrhosis. It is not discriminatory. [cite:Robbins 10e Ch 20]